Grants

awarded

The METAvivor Research Program was established in 2009 with the specific goal of funding stage IV metastatic breast cancer research to one day, end death from metastatic breast cancer (MBC). The following list includes current and past grant recipients along with their progress reports.

SOPHIA LUNT, PhD

Michigan State University

Targeting Sialic Acid Metabolism to Stop Metastatic Breast Cancer

Traci Lyons, PhD

University of Colorado Anschutz Medical Campus

Presented by Northwest Arkansas Metsquerade In Memory of Erin Leland

Targeting therapeutic vulnerabilities of endocrine therapy resistant ER+ metastatic breast cancer

Ashley Makela, PhD

The Institute for Quantitative Health Science and Engineering, Michigan State University

Presented In Memory of Connie Cadwell by Miles4Metavivor

Understanding extracellular vesicle trafficking in established breast cancer metastases: In vivo tri-modal imaging provides long

Srinivas Malladi, PhD

UT Southwestern Medical Center

Presented in Honor of Abbey Rapoport

Targeting vulnerabilities of immune-evasive HER2+ Breast Adenocarcinoma Metastasis Initiating Cells

SENDURAI A. MANI, PhD

University of Texas MD Anderson Cancer Center

Targeting Cancer Stem Cells to Treat Metastasis

Stuart Martin, PhD

University of Maryland School of Medicine

Presented In Memory of Wendy Taylor by Northwest Arkansas Metsquerade

Reducing the risk of chemotherapy-induced scattering of metastatic triple-negative breast tumors

Stuart S. Martin, PhD

University of Maryland, Baltimore

Presented in memory of Kerry O’Riordan McAdam and in honor of Jacqueline Beck

Leveraging combined ctDNA and CTC analysis to optimize treatment for existing bone metastases

Stuart Martin, PhD

University of Maryland School of Medicine

Presented by the We “Neeta” Cure Fundraiser in Memory of Neta Meier

Targeting Tau-induced microtubule stabilization to reduce outgrowth of metastatic tumors

Julie Di Martino, PhD

Icahn School of Medicine at Mount Sinai

Targeting dormant breast cancer cells with ACE inhibitors

Andrea M. Mastro, PhD

The Pennsylvania State University

Dormancy or growth? A three dimensional in vitro system to study breast cancer metastases in bone

Sandra McAllister, PhD

Brigham and Women’s Hospital; Harvard Medical School

Presented In Memory of Lauren Smoke by Chicago Metsquerade

A new approach to identifying effective therapeutic strategies that eliminate de novo and recurrent stage IV triple-negative bre

ELIZABETH MCDONALD, MD, PhD

University of Pennsylvania

In vivo visualization and quantification of pharmacodynamics response to PARPi therapy